Orthofix Medical (OFIX) Capital Leases (2019 - 2026)

Orthofix Medical has disclosed Capital Leases across 8 years of filings, most recently posting $12.9 million for Q1 2026.

• Quarterly Capital Leases fell 26.64% year-over-year to $12.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.9 million (down 26.64% YoY) and the FY2025 annual result came in at $17.1 million, down 4.35% from the prior year.
• Capital Leases declined to $12.9 million in Q1 2026, from $17.1 million in the prior quarter.
• Over five years, Capital Leases peaked at $19.7 million in Q1 2022 and troughed at $12.9 million in Q1 2026.
• A 5-year average of $18.1 million and a median of $18.3 million in 2024 frame the typical range for Capital Leases.
• Annual changes were most pronounced in 2022 — Capital Leases retreated 2.73% — and 2026, when it fell 26.64%.
• Tracing OFIX's Capital Leases over 5 years: stood at $19.2 million in 2022, then retreated by 3.67% to $18.5 million in 2023, then declined by 3.76% to $17.8 million in 2024, then decreased by 4.35% to $17.1 million in 2025, then declined by 24.17% to $12.9 million in 2026.
• Business Quant data shows OFIX's Capital Leases at $12.9 million in Q1 2026, $17.1 million in Q4 2025, and $17.2 million in Q3 2025.